GIT Flashcards
Features of FB that will not pass the GIT
Irregular<br></br>Sharp<br></br>Wide objects (wider than 2.5 cm or longer than 6 cm)<br></br>
Complications of stuck FB
Airway obstruction<br></br>Stricture<br></br>Perforation<br></br>Corrosion<br></br>Erosion<br></br>Aspiration pneumonia/pneumonitis
Indications for urgent endoscopy in FB
Sharp objects<br></br>Multiple FBs<br></br>Button batteries<br></br>Perforation<br></br>Coin at the level of cricopharyngeus in children<br></br>Airway compromise<br></br>FB for > 24 hrs
Causes of Massive UGIB
PUD<br></br>Esophageal varices<br></br>Aorto-enteric fistula
Indication for massive transfusion in UGIB
Hemodynamic instability<br></br>Shock index (HR/SBP)>1<br></br>Pt presented with presyncope<br></br>Brisk bleeding<br></br>Co-morbidities (CAD, coagulopathy)
Tests to order during an MTP
CBC for plt count<br></br>INR (correct if > 1.8)<br></br>PTT<br></br>Fibrenogen (to assess the need for cryoppt)
<strong>Contraindications to tranexamic acid</strong>
<ul><li>History of coronary stent(s)</li><li>History of active hematuria (it is thought that administration of TXA in the patient with hematuria may cause a clot resulting in obstructive uropathy)</li><li>History of venous thromboembolic disease</li></ul>
“<h3><span><strong>Order of priority of IV medications in upper GI bleed emergencies</strong></span></h3>”
<ol><li><strong>Ceftriaxone</strong>1 g IV for all cirrhotics</li><li><strong>Octreotide 50</strong><strong>μ</strong><strong>g bolus + 50</strong><strong>μ</strong><strong>g/hr infusion</strong>for all UGIB patients</li><li><strong>Erythromycin250mg,</strong>30 minutes prior to endoscopy for suspected peptic ulcer</li><li><strong>PPI e.g. Pantaprazole 80 mg IV bolus</strong>(no infusion necessary) –once you’ve given everything else, if the endoscopist asks for it</li></ol>
Mx of GIT bleeding
“<img></img>”
What historical factors that can help sorting out reasons for GIT bleeding?
Medication<br></br>Substance abuse<br></br>Constitutional symp<br></br>Stigmata of liver dis<br></br>Coagulopathy
Initial Mx of UGIB
“<img></img>”
The patient’s vitals do not improve, what is your next steps in management
• Massive Transfusion Protocol<br></br>• Reverse coagulopathy <br></br>• Place nasogastric tube<br></br>• Consult gastroenterologist (GI) for emergent (EGD)<br></br>• If unstable consider Blakemore tube
DDX for blood in stool
• PUD<br></br>• Gastritis<br></br>• Esophageal or gastric varices<br></br>• Mallory Weiss syndrome<br></br>• Dielafoy lesions<br></br>• Avm malformations<br></br>• Malignancy<br></br>• Zollinger Ellison Syndrome: gastrin tumor
Risk Factors ofPUD
• EtOH <br></br>• H. Pylori<br></br>• NSAIDS<br></br>• Steroids<br></br>• Aortic graft
Meds in GIT bleeding
• Octeotide 50mcg/50mcg/hr<br></br>• PPI 80 mg bolus and then 40 mg IV BID<br></br>• ABX - for patients with Cirrhosis: Ceftriaxone or Cipro<br></br>• Consider Erythromycin 3mg/kg IV over 30 min, 30 min prior to scope
Ind of D/C of UGIB
If Glasgow Blachford Score=0:<br></br>No co-morbid dis<br></br>Normal VS<br></br>Normal Hb<br></br>Neg or trac FOB<br></br>Good home support<br></br>Competent/reliable pt<br></br>F/U within 24 hrs